Marshall's technique promises to prevent and even reverse the process, allowing the eye to return to something like its youthful, uncluttered state. In a clinical trial involving more than 100 diabetics, Marshall found that focusing a laser beam on one part of the retina helps stimulate the release of enzymes, which then set about cleaning up the waste material. Participants reported this led to a marked improvement in their sight.
And we’re coming up on the fiftieth anniversary of the laser (2010), too.
I hope this can become replicated and used to restore the eyesight of many who suffer from this. As diabetes becomes more prominent, many more over the years will suffer vision loss and blindness. If this can reverse this process and be available under major insurance plans, it could be a godsend.
Of course, if you’re under Nationalized health care, you may be considered too “high risk” for treatment and told you deserve to be blind for all the sodas you drank and the cheeseburgers you ate, etc.
Oh and by the way UK denies macular degeneration treatments.
“In 2007, the board restricted access to two drugs for macular degeneration, a cause of blindness. The drug Macugen was blocked outright. The other, Lucentis, was limited to a particular category of individuals with the disease, restricting it to about one in five sufferers. Even then, the drug was only approved for use in one eye, meaning those lucky enough to get it would still go blind in the other. As Andrew Dillon, the chief executive of NICE, explained at the time: “When treatments are very expensive, we have to use them where they give the most benefit to patients.”
Wall Street Journal Editorial
* The Wall Street Journal
* REVIEW & OUTLOOK
* JULY 7, 2009
Of NICE and Men
Denied by virtue of Obamacare. NEXT!
I just showed this article to my boss (a leading Ophthalmologist) and he said he believes this has been debunked. Basically this was done on people who had macular drusen (not just macular degeneration) and they were essentially lasering the drusen off. It looked better as far as the macula went, but did not show any improvement in the patient’s vision. He said it would be wonderful if it worked but he doesn’t believe it does.